Avalyn Pharma Inc. Common Stock (AVLN) — Defensive Interval Ratio
Avalyn Pharma Inc. Common Stock (AVLN) has a Defensive Interval Ratio of 3036 days as of June 2026. Defensive assets of $89.90 Million (cash $-, short-term investments $88.23 Million, receivables $1.67 Million) cover 3036 days of daily cash needs of $29.61K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Avalyn Pharma Inc. Common Stock Defensive Interval Ratio (2024–2025)
This chart shows how Avalyn Pharma Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the ratio stands at 3036 days, meaning defensive assets of $89.90 Million can fund 3036 days of operations without new revenue. For the complete balance sheet picture, see Avalyn Pharma Inc. Common Stock balance sheet assets.
Annual Defensive Interval Ratio for Avalyn Pharma Inc. Common Stock (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for Avalyn Pharma Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See AVLN current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2243 days | $86.58 Million | $38.61K/day | $- | $86.04 Million | ▼ -1375 days |
| 2024 | 3618 days | $86.67 Million | $23.96K/day | $- | $86.67 Million | — |